OPEN ORPHAN
Open Orphan Open Orphan is a rapidly growing niche CRO pharmaceutical services group which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe's only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility. Which offers highly specialised virology and immunology laboratory services to support pre-clinical and clinical respiratory drug, antiviral, and vaccine discovery and development.
OPEN ORPHAN
Industry:
Life Science Pharmaceutical
Founded:
2011-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.openorphan.com
Total Employee:
1+
Status:
Active
Contact:
+353 (01) 6440007
Email Addresses:
[email protected]
Total Funding:
6.3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Mobile Non Scaleable Content Microsoft Exchange Online
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Nuclera
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Stock Details
Investors List
Raglan Capital
Raglan Capital investment in Post-IPO Equity - Open Orphan
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-24 | Open Orphan names Khan as new CEO |
Official Site Inspections
http://www.openorphan.com
- Host name: ec2-52-17-142-199.eu-west-1.compute.amazonaws.com
- IP address: 52.17.142.199
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Open Orphan"
Open Orphan - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +353 (01) 6440007 Open Orphan Open Orphan is a rapidly growing niche CRO pharmaceutical services group which is a world leader …See details»
About Us | World Leaders in Clinical Trials - hVIVO
Group companies overview. In January 2020, hVIVO merged with Open Orphan plc, a rapidly growing niche CRO pharmaceutical services company. On 26 October 2022, Open Orphan plc …See details»
Open Orphan | Hardman & Co
Jul 14, 2020 Open Orphan plc is a European-focussed, rare and orphan drug consulting services platform. The Company consists of four elements: a European clinical research …See details»
Open Orphan Plc - valuethemarkets.com
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical …See details»
Open Orphan - Craft
Dec 23, 2022 Open Orphan €48.48 m in annual revenue in FY 2022. See insights on Open Orphan including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Open Orphan plc Company Profile & Data: stocks, market cap, …
Jan 1, 2025 Company. Open Orphan plc. Headquarters: London, United Kingdom Employees: 179. CEO: Dr. Yamin Mohammed Khan Ph.D.See details»
Open Orphan - Overview, News & Similar companies - ZoomInfo
Oct 17, 2022 View Open Orphan (www.openorphan.com) location in Greater London, United Kingdom , revenue, industry and description. ... ORPH), a rapidly growing specialist contract …See details»
Open Orphan - VentureRadar
Website: https://www.openorphan.com/ hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the ...See details»
Open Orphan - Biotech Careers
Open Orphan is a niche contract research organization (CRO) which is the world leader in testing infectious and respiratory disease products using human challenge clinical trials. Business …See details»
Nextsource | Company Profile | Open Orphan
Explore the company profile of Open Orphan (openorphan.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Open Orphan - Company info. interviews, news
Open Orphan is a rapidly growing niche CRO pharmaceutical services group which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials.See details»
Open Orphan CEO and Key Executive Team | Craft.co
Open Orphan's Executive Chairman is Cathal Friel. Other executives include Leo Toole, Chief Financial Officer; Andrew Catchpole, Chief Scientific Officer and 4 others. See the full …See details»
Open Orphan facing up to Covid challenge - hVIVO
Www.openorphan.com February 2021 Spotlight company profile kindly reproduced with permission from Shares magazine – www.sharesmagazine.co.uk Open Orphan plc …See details»
Open Orphan reiterates £50m profit guidance ... - The Irish Times
Sep 8, 2022 However, the company reiterated its £50 million (€57.5 million) profit guidance for 2021, underpinned by robust trading in July and August.See details»
Open Orphan rebrands to Hvivo as it focuses on human challenge …
Sep 8, 2022 Open Orphan is changing its name as CEO Yamin Khan said the company achieved its ‘key goal’ of double-digit earnings for the first time. Dublin-based pharma services …See details»
Open Orphan 2020 Year in Review - YouTube
Dec 7, 2020 Open Orphan CEO, Cathal Friel, outlines the highlights of 2020 including the transformative acquisition of Hvivo and major contract wins. In addition he disc...See details»
Open Orphan to merge with UK-based Hvivo in £30m tie-up
Dec 9, 2019 Dublin-listed pharma services company Open Orphan said on Monday it has agreed to merge with UK-based Hvivo in a £30 million (€35.7m) tie-up that classifies it as a …See details»
Open Orphan sees revenues grow in ‘milestone’ year
Jun 7, 2022 Revenues at Open Orphan grew 76 per cent last year in what the company described as a “milestone” year for the specialist contract research organisation.See details»
Open Orphan Plc (@openorphan) • Instagram photos and videos
101 Followers, 37 Following, 91 Posts - Open Orphan Plc (@openorphan) on Instagram: "We have changed our name to hVIVO plc, ticker: HVO. Follow hVIVO on Facebook, LinkedIn or …See details»
OpenOrphan - Reddit
R/OpenOrphan: Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines - Open … Press J to jump to the feed. Press …See details»